MAM
ADVM

Meeder Asset Management’s Adverum Biotechnologies ADVM Stock Holding History

Meeder Asset Management’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-688
Closed -$24K – 2463
2021
Q2 		$24K Buy
688
+345
+101% +$18.6K ﹤0.01% 1395
2021
Q1 		$35K Buy
+343
New +$41.2K ﹤0.01% 1217
2020
Q4 		– Sell
-119
Closed -$12K – 1845
2020
Q3 		$12K Sell
119
-176
-60% -$26.4K ﹤0.01% 1303
2020
Q2 		$62K Buy
295
+131
+80% +$23.2K ﹤0.01% 879
2020
Q1 		$16K Buy
164
+52
+46% +$6.06K ﹤0.01% 1322
2019
Q4 		$14K Sell
112
-151
-57% -$13.3K ﹤0.01% 1453
2019
Q3 		$14K Sell
263
-806
-75% -$90.8K ﹤0.01% 1417
2019
Q2 		$127K Buy
1,069
+842
+371% +$69.7K 0.01% 692
2019
Q1 		$12K Sell
227
-73
-24% -$2.95K ﹤0.01% 1188
2018
Q4 		$9K Buy
300
+253
+538% +$10.3K ﹤0.01% 1269
2018
Q3 		$3K Buy
+47
New +$2.64K ﹤0.01% 1393
2018
Q1 		– Sell
-155
Closed -$5K – 1547
2017
Q4 		$5K Hold
155
– – ﹤0.01% 1299
2017
Q3 		$6K Hold
155
– – ﹤0.01% 1192
2017
Q2 		$4K Hold
155
– – ﹤0.01% 1234
2017
Q1 		$4K Sell
155
-252
-62% -$7.17K ﹤0.01% 1142
2016
Q4 		$12K Buy
+407
New +$13.3K ﹤0.01% 720

Other funds holding ADVM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Meeder Asset Management's ADVM Position: Q3 2021 in Review

Meeder Asset Management sold out of Adverum Biotechnologies (ADVM) in Q3 2021, closing a stake of 688 shares — an estimated $24K sold.

Meeder Asset Management first reported a position in ADVM in Q4 2016 and held it in 16 quarters. The position peaked at $127K in Q2 2019. 110 funds tracked by Wall St. Rank hold ADVM as of Q3 2021.

  • Meeder Asset Management reported no remaining Adverum Biotechnologies position as of Q3 2021 after selling out during the quarter.
  • Meeder Asset Management sold 688 Adverum Biotechnologies shares in Q3 2021, an estimated $24K.
  • Meeder Asset Management first reported a position in Adverum Biotechnologies in Q4 2016 and held it in 16 quarters.
  • Meeder Asset Management's Adverum Biotechnologies position peaked at $127K in Q2 2019.
  • 110 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2021.

Based on Meeder Asset Management's 13F filing for Q3 2021, filed 8 Nov 2021.